title: [Progressive multifocal leukoencephalopathy in a patient with acute myeloid leukaemia after allogeneic hematopoietic-cell transplantation].
authors.forename: Mario
authors.initials: M
authors.lastname: Fernández-Ruiz
authors.forename: Javier
authors.initials: J
authors.lastname: de la Serna
authors.forename: Juan
authors.initials: J
authors.lastname: Ruiz
authors.forename: Francisco
authors.initials: F
authors.lastname: López-Medrano
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects / Q000627:therapeutic use; D003131:Combined Modality Therapy; D017809:Fatal Outcome; D006086:Graft vs Host Disease / Q000517:prevention & control; D018380:Hematopoietic Stem Cell Transplantation / Q000009:adverse effects*; D006801:Humans; D016867:Immunocompromised Host; D007166:Immunosuppressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D015470:Leukemia, Myeloid, Acute / Q000150:complications / Q000188:drug therapy / Q000601:surgery*; D007968:Leukoencephalopathy, Progressive Multifocal / Q000188:drug therapy / Q000209:etiology*; D008297:Male; D008803:Mianserin / Q000031:analogs & derivatives / Q000627:therapeutic use; D008875:Middle Aged; D000078785:Mirtazapine; D011183:Postoperative Complications / Q000209:etiology*; D014184:Transplantation, Homologous / Q000009:adverse effects
chemical_list: D007166:Immunosuppressive Agents; D008803:Mianserin; D000078785:Mirtazapine